Inventor · disambiguated record
Katharigatta N. Venugopala
Also filed as: VENUGOPALA KATHARIGATTA N
42 granted patents·1 pending application·4 citations·filing 2022–2024
94Inventor score
Top patents by PatentIndex Score
43 records- 0192US11807640B17-isopropyl 1-ethyl/methyl 3-(substituted benzoyl)-2-substituted indolizine-1,7-dicarboxylates as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted Nov 7, 2023·2 cites·16 claims
- 0292US11530217B1Antitubercular compoundsUNIV KING FAISAL·Filed 2022·Granted Dec 20, 2022·2 cites·11 claims
- 0377US12145915B1(E)-2-(3-cyano-4-isobutoxyphenyl)-n′-(substituted benzylidene)-4-methylthiazole-5-carbohydrazides as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted Nov 19, 2024·0 cites·13 claims
- 0477US11981674B17-isopropyl 1-ethyl/methyl 3-(substituted benzoyl)-2-substituted indolizine-1,7-dicarboxylates as larvicidal agentsUNIV KING FAISAL·Filed 2023·Granted May 14, 2024·0 cites·17 claims
- 0577US11964982B15-(3-substituted phenyl)-pyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,8H)-trione derivatives as anticancer agentsUNIV KING FAISAL·Filed 2023·Granted Apr 23, 2024·0 cites·6 claims
- 0677US11884677B15-(substitutedphenyl)-7-imino-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as anti-inflammatory agentsUNIV KING FAISAL·Filed 2023·Granted Jan 30, 2024·0 cites·14 claims
- 0776US12172973B1(E)-2-(3-Cyano-4-isobutoxyphenyl)-N′-(substituted benzylidene)-4-methylthiazole-5-carbohydrazides as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted Dec 24, 2024·0 cites·2 claims
- 0875US12297204B25-(substitutedphenyl)-7-thioxo-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as antibacterial agentsUNIV KING FAISAL·Filed 2024·Granted May 13, 2025·0 cites·8 claims
- 0975US12221450B15-(substitutedphenyl)-7-thioxo-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as antibacterial agentsUNIV KING FAISAL·Filed 2024·Granted Feb 11, 2025·0 cites·14 claims
- 1074US11976076B1Substituted 7,8-dihydropyrimido[4,5-d]pyrimidines as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted May 7, 2024·0 cites·20 claims
- 1174US11919860B11-2(-(substituted phenyl)-2-oxoethyl)-4-(isopropoxycarbonyl)pyridin-1-ium bromides as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted Mar 5, 2024·0 cites·16 claims
- 1273US12187733B15-(Substitutedphenyl)-7-Imino-7,8-Dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as anti-inflammatory agentsUNIV KING FAISAL·Filed 2023·Granted Jan 7, 2025·0 cites·8 claims
- 1373US12145936B17-Imino-5-(1H-indol-3-yl)-1,3-substituted-7,8-dihdropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione as anti-inflammatory agentsUNIV KING FAISAL·Filed 2023·Granted Nov 19, 2024·0 cites·17 claims
- 1473US11958857B15-(1H-indol-3-yl)-1,3-substitutedpyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,8H)-trione as anticancer agentsUNIV KING FAISAL·Filed 2023·Granted Apr 16, 2024·0 cites·13 claims
- 1572US12215082B1(e)-1-(2-(4-substitutedphenyl)-2-oxoethyl)-4-((hydroxyimino)methyl)pyridinium bromides as antitubercular agentsUNIV KING FAISAL·Filed 2024·Granted Feb 4, 2025·0 cites·9 claims
- 1672US11976066B1Substituted 7-amino-3-(substituted benzoyl)indolizine-1-carboxylates as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted May 7, 2024·0 cites·11 claims
- 1772US11932649B15-(3-substituted phenyl)-pyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,8H)-trione derivatives as anticancer agentsKING FAISAL UNIVERISTY·Filed 2023·Granted Mar 19, 2024·0 cites·13 claims
- 1872US11926602B14-amino-5-(4-fluoro-3-phenoxyphenyl)-4H-1,2,4-triazole-3-thiol derivatives as antifungal agentsUNIV KING FAISAL·Filed 2023·Granted Mar 12, 2024·0 cites·10 claims
- 1972US11926627B1Substituted 7-methyl quinoline derivatives as antitubercular agentsUNIV KING FAISAL·Filed 2023·Granted Mar 12, 2024·0 cites·14 claims
- 2071US11987563B13-cyano 4,5-diphenyl furan-2-carboxamides as antitubercular agentsUNIV KING FAISAL·Filed 2023·Granted May 21, 2024·0 cites·4 claims
- 2171US11845746B1Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted Dec 19, 2023·0 cites·8 claims
- 2270US12227480B11-(2-(substituted phenyl)-2-oxoethyl)-4-methylpyridin-1-ium bromide as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted Feb 18, 2025·0 cites·5 claims
- 2370US11970470B1{5-chloro-2-(2-(3-(substitutedphenyl)-1,2,4-oxadiazol-5-yl)ethyl)phenyl}(phenyl)methanones as larvicidal agentsUNIV KING FAISAL·Filed 2023·Granted Apr 30, 2024·0 cites·18 claims
- 2470US11945819B1Dimethyl 7-bromo-1-(4-substituted benzoyl)pyrrolo[1,2-a]quinoline-2,3-dicarboxylates as anti-inflammatory agentsUNIV KING FAISAL·Filed 2023·Granted Apr 2, 2024·0 cites·17 claims
- 2570US11884631B1Substituted phenyl quinolin-l-ium bromide derivative as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted Jan 30, 2024·0 cites·18 claims
- 2669US11939294B11-(2-(substituted phenyl)-2-oxoethyl)-3,5-dimethylpyridin-1-ium bromides as antitubercular agentsUNIV KING FAISAL·Filed 2023·Granted Mar 26, 2024·0 cites·8 claims
- 2769US11912683B1(6-methyl-4-substitutedphenyl-2-oxo/thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)(piperidin-1-yl)methanones as antitubercular agentsUNIV KING FAISAL·Filed 2023·Granted Feb 27, 2024·0 cites·3 claims
- 2867US11919900B11-substituted benzoyl-4-bromopyrrolo[1,2-a]quinoline-3-carboxylate derivatives as antitubercular agentsUNIV KING FAISAL·Filed 2023·Granted Mar 5, 2024·0 cites·17 claims
- 2967US11905279B1Benzylidene derivatives of fenobam as anti-inflammatory agentsUNIV KING FAISAL·Filed 2023·Granted Feb 20, 2024·0 cites·20 claims
- 3066US12202801B14-cyano-1-(2-oxo-2-(substituted phenyl) ethyl) pyridin-1-ium bromides as anti-tubercular agentsUNIV KING FAISAL·Filed 2024·Granted Jan 21, 2025·0 cites·12 claims
- 3166US11981643B1Oxoimidazolidine derivatives as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted May 14, 2024·0 cites·14 claims
- 3266US11970489B14-[(substituted 1H-benzimidazol-2-ylsulfanyl)methyl]-6-substituted-2H-chromen-2-ones as larvicidal agentsUNIV KING FAISAL·Filed 2023·Granted Apr 30, 2024·0 cites·18 claims
- 3366US11938120B1Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted Mar 26, 2024·0 cites·16 claims
- 3466US11807553B1Decontamination of water using guar gum derivatives and applications thereofUNIV KING FAISAL·Filed 2023·Granted Nov 7, 2023·0 cites·10 claims
- 3565US11998532B1Substituted 1,3,4-oxadiazole derivatives as anti-tubercular agentsUNIV KING FAISAL·Filed 2023·Granted Jun 4, 2024·0 cites·16 claims
- 3665US11981673B17-isopropyl 1,2-dimethyl 3-(substituted benzoyl)indolizine-1,2,7 tricarboxylates as adenosine receptor active compoundsUNIV KING FAISAL·Filed 2023·Granted May 14, 2024·0 cites·17 claims
- 3763US12227516B1Selective COX-2 inhibition of 2-(substituted benzyl)-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-ones and 4-fluoro-n-(4-oxo-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl)benzamide as anti-inflammatory agentsUNIV KING FAISAL·Filed 2023·Granted Feb 18, 2025·0 cites·4 claims
- 3863US11986476B1(6-methyl-4-substitutedphenyl-2-oxo/thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)(piperidin-1-yl)methanones as antitubercular agentsUNIV KING FAISAL·Filed 2023·Granted May 21, 2024·0 cites·4 claims
- 3963US11974991B1Adenosine receptor activity of methyl/ethyl 3-(substituted benzoyl)-6,8-dimethylindolizine-2-substituted-1-carboxylatesUNIV KING FAISAL·Filed 2023·Granted May 7, 2024·0 cites·7 claims
- 4061US12194029B1Ethyl-1-(substitutedbenzoyl)-5-methylpyrrolo[1,2-a]quinoline-3-carboxylates as anticancer agentsUNIV KING FAISAL·Filed 2023·Granted Jan 14, 2025·0 cites·11 claims
- 4160US11932656B1Thieno[2,3-d]pyrimidines as COX-2 inhibitorsUNIV KING FAISAL·Filed 2023·Granted Mar 19, 2024·0 cites·16 claims
- 4260US11932609B1Substituted 1,4-dihydropyrimidines as antitubercular agentsUNIV KING FAISAL·Filed 2023·Granted Mar 19, 2024·0 cites·20 claims
- 4356US2024325325A1Liposome encapsulating cysteamine and resveratrol in separate compartmentsUNIV KING FAISAL·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Katharigatta N. Venugopala files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →